Biogen issues early data on potential game-changing MS drug. Investors shrug.

... BIIB) is one of the few drug companies in the world working on such a drug, the only other one I know of being Ardsley, N.Y.-based Acorda Therapeutics , which has a presence in the Boston area through its recent acquisition of Civitas Therapeutics . ...

http://ift.tt/1Fv8zKs